N1-Methyl-lysergic acid diethylamide
From Wikipedia, the free encyclopedia
(Redirected from MLD-41)
 |
The topic of this article may not meet Wikipedia's general notability guideline. (April 2015) (Learn how and when to remove this template message) |
 |
|
| Clinical data | |
|---|---|
| Routes of administration |
Oral |
| Pharmacokinetic data | |
| Metabolism | hepatic |
| Excretion | renal |
| Identifiers | |
|
|
| Synonyms | MLD-41, N1- Methyl- Lysergic Acid Diethylamide |
| CAS Number | 4238-85-1  |
| PubChem (CID) | 165200 |
| ChemSpider | 144824 |
| Chemical and physical data | |
| Formula | C21H27N3O |
| Molar mass | 337.47 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (verify) | |
N1-Methyl-lysergic acid diethylamide (MLD-41) is a derivative of LSD.
Metabolism of other 1-methylated-ergoloids to their secondary amine derivatives has been frequently noted in mammals.[1]
References[edit]
- ^ Müller-Schweinitzer and Tapparelli (1986). Methylergometrine, an active metabolite of methysergide. Cephalalgia. 6: 35-41.
 |
This Hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
